Abstract
An increased susceptibility to infectious diseases in the setting of opiate use has long been noted. Studies on the specific roles of opiates in immune cells using opioid agonists and antagonists reveal a broad array of effects that include altered T and B cell proliferation, antibody production, natural killer cell activity, and cytokine production. The complexity of these effects in the setting of multiple opioid receptor subtypes has only recently been recognized. Novel, receptor-specific opioid antagonists permit more robust studies on the protean effects of these agents on immune cells. This chapter will emphasize what is known about the biologic and clinical effects of opioids on immune function with a focus on the role of opioid antagonists.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alicea, C., Belkowski, S. M., Sliker, J. K., Zhu, J., Liu-Chen, L. Y., Eisenstein, T. K., Adler, M. W., & Rogers, T. J. (1998). Characterization of kappa-opioid receptor transcripts expressed by T cells and macrophages. J Neuroimmunol, 91(1–2), 55–62.
Apte, R. N., Durum, S. K., & Oppenheim, J. J. (1990). Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol Lett, 24(2), 141–148.
Ausiello, C. M., & Roda, L. G. (1984). Leu-enkephalin binding to cultured human T lymphocytes. Cell Biol Int Rep, 8(5), 353–362.
Bare, L. A., Mansson, E., & Yang, D. (1994). Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett, 354(2), 213–216.
Bayer, B. M., Daussin, S., Hernandez, M., & Irvin, L. (1990). Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neuropharmacology, 29(4), 369–374.
Belkowski, S. M., Alicea, C., Eisenstein, T. K., Adler, M. W., & Rogers, T. J. (1995). Inhibition of interleukin-1 and tumor necrosis factor-alpha synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J Pharmacol Exp Ther, 273(3), 1491–1496.
Belkowski, S. M., Zhu, J., Liu-Chen, L. Y., Eisenstein, T. K., Adler, M. W., & Rogers, T. J. (1995). Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line. J Neuroimmunol, 62(1), 113–117.
Bessler, H., Sztein, M. B., & Serrate, S. A. (1990). Beta-endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology, 19(1), 5–14.
Bhargava, H. N., Thomas, P. T., Thorat, S., & House, R. V. (1994). Effects of morphine tolerance and abstinence on cellular immune function. Brain Res, 642(1–2), 1–10.
Bidlack, J. M. (2000). Detection and function of opioid receptors on cells from the immune system. Clin Diagn Lab Immunol, 7(5), 719–723.
Bidlack, J. M., Lawrence, D. M., & Ignatowski, T. A. (1996). Kappa opioid receptors on immune cells as studied by fluorescent ligands. Adv Exp Med Biol, 402, 13–22.
Brown, S. L., & Van Epps, D. E. (1986). Opioid peptides modulate production of interferon gamma by human mononuclear cells. Cell Immunol, 103(1), 19–26.
Bryant, H. U., & Roudebush, R. E. (1990). Suppressive effects of morphine pellet implants on in vivo parameters of immune function. J Pharmacol Exp Ther, 255(2), 410–414.
Bryant, H. U., Bernton, E. W., & Holaday, J. W. (1987). Immunosuppressive effects of chronic morphine treatment in mice. Life Sci, 41(14), 1731–1738.
Bryant, H. U., Bernton, E. W., & Holaday, J. W. (1988). Morphine pellet-induced immu-nomodulation in mice: temporal relationships. J Pharmacol Exp Ther, 245(3), 913–920.
Bryant, H. U., Bernton, E. W., & Holaday, J. W. (1990). Immunomodulatory effects of chronic morphine treatment: pharmacologic and mechanistic studies. NIDA Res Monogr, 96, 131–149.
Bussiere, J. L., Adler, M. W., Rogers, T. J., & Eisenstein, T. K. (1992). Differential effects of morphine and naltrexone on the antibody response in various mouse strains. Immunopharmacol Immunotoxicol, 14(3), 657–673.
Bussiere, J. L., Adler, M. W., Rogers, T. J., & Eisenstein, T. K. (1993). Cytokine reversal of morphine-induced suppression of the antibody response. J Pharmacol Exp Ther, 264(2), 591–597.
Carr, D. J., Kim, C. H., deCosta, B., Jacobson, A. E., Rice, K. C., & Blalock, J. E. (1988). Evidence for a delta-class opioid receptor on cells of the immune system. Cell Immunol, 116(1), 44–51.
Carr, D. J., DeCosta, B. R., Kim, C. H., Jacobson, A. E., Guarcello, V., Rice, K. C., & Blalock, J. E. (1989). Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes. J Endocrinol, 122(1), 161–168.
Chao, C. C., Sharp, B. M., Pomeroy, C., Filice, G. A., & Peterson, P. K. (1990). Lethality of morphine in mice infected with Toxoplasma gondii. J Pharmacol Exp Ther, 252(2), 605–609.
Chao, C. C., Hu, S., Molitor, T. W., Zhou, Y., Murtaugh, M. P., Tsang, M., & Peterson, P. K. (1992). Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther, 262(1), 19–24.
Chao, C. C., Gekker, G., Hu, S., Sheng, W. S., Portoghese, P. S., & Peterson, P. K. (1995). Upregulation of HIV-1 expression in cocultures of chronically infected promonocytes and human brain cells by dynorphin. Biochem Pharmacol, 50(5), 715–722.
Chuang, L. F., Chuang, T. K., Killam, K. F., Jr., Chuang, A. J., Kung, H. F., Yu, L., & Chuang, R. Y. (1994). Delta opioid receptor gene expression in lymphocytes. Biochem Biophys Res Commun, 202(3), 1291–1299.
Chuang, L. F., Chuang, T. K., Killam, K. F., Jr., Qiu, Q., Wang, X. R., Lin, J. J., Kung, H. F., Sheng, W., Chao, C., Yu, L., et al. (1995). Expression of kappa opioid receptors in human and monkey lymphocytes. Biochem Biophys Res Commun, 209(3), 1003–1010.
Chuang, T. K., Killam, K. F., Jr., Chuang, L. F., Kung, H. F., Sheng, W. S., Chao, C. C., Yu, L., & Chuang, R. Y. (1995). Mu opioid receptor gene expression in immune cells. Biochem Biophys Res Commun, 216(3), 922–930.
Eguchi, M. (2004). Recent advances in selective opioid receptor agonists and antagonists. Med Res Rev, 24(2), 182–212.
Eisenstein, T. K., Meissler, J. J., Jr., Rogers, T. J., Geller, E. B., & Adler, M. W. (1995). Mouse strain differences in immunosuppression by opioids in vitro. J Pharmacol Exp Ther, 275(3), 1484–1489.
Falke, N. E., Fischer, E. G., & Martin, R. (1985). Stereospecific opiate binding in living human polymorphonuclear leucocytes. Cell Biol Int Rep, 9(11), 1041–1047.
Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1993). Alterations of immune status induced by the sympathetic nervous system: immunomodulatory effects of DMPP alone and in combination with morphine. Brain Behav Immun, 7(3), 253–270.
Fecho, K., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1996). Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther, 276(2), 626–636.
Fiorica, E., & Spector, S. (1988). Opioid binding site in EL-4 thymoma cell line. Life Sci, 42(2), 199–206.
Fowler, C. J., & Fraser, G. L. (1994). Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments. Neurochem Int, 24(5), 401–426.
Freier, D. O., & Fuchs, B. A. (1993). Morphine-induced alterations in thymocyte subpopula-tions of B6C3F1 mice. J Pharmacol Exp Ther, 265(1), 81–88.
Freier, D. O., & Fuchs, B. A. (1994). A mechanism of action for morphine-induced immuno-suppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther, 270(3), 1127–1133.
Fuchs, B. A., & Pruett, S. B. (1993). Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J Pharmacol Exp Ther, 266(1), 417–423.
Govitrapong, P., Suttitum, T., Kotchabhakdi, N., & Uneklabh, T. (1998). Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J Pharmacol Exp Ther, 286(2), 883–889.
Guan, L., Townsend, R., Eisenstein, T. K., Adler, M. W., & Rogers, T. J. (1994). Both T cells and macrophages are targets of kappa-opioid-induced immunosuppression. Brain Behav Immun, 8(3), 229–240.
Halford, W. P., Gebhardt, B. M., & Carr, D. J. (1995). Functional role and sequence analysis of a lymphocyte orphan opioid receptor. J Neuroimmunol, 59(1–2), 91–101.
Heagy, W., Teng, E., Lopez, P., & Finberg, R. W. (1999). Enkephalin receptors and receptor-mediated signal transduction in cultured human lymphocytes. Cell Immunol, 191(1), 34–48.
Hernandez, M. C., Flores, L. R., & Bayer, B. M. (1993). Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther, 267(3), 1336–1341.
Hilburger, M. E., Adler, M. W., Rogers, T. J., & Eisenstein, T. K. (1997). Morphine alters macrophage and lymphocyte populations in the spleen and peritoneal cavity. J Neuroimmunol, 80(1–2), 106–114.
Hoffman, K. E., Maslonek, K. A., Dykstra, L. A., & Lysle, D. T. (1995). Effects of central administration of morphine on immune status in Lewis and Wistar rats. Adv Exp Med Biol, 373, 155–159.
Jessop, J. J., & Taplits, M. S. (1991). Effect of high doses of morphine on Con-A induced lymphokine production in vitro. Immunopharmacology, 22(3), 175–184.
Lawrence, D. M., el-Hamouly, W., Archer, S., Leary, J. F., & Bidlack, J. M. (1995). Identification of kappa opioid receptors in the immune system by indirect immunofluores-cence. Proc Natl Acad Sci U S A, 92(4), 1062–1066.
Linner, K. M., Quist, H. E., & Sharp, B. M. (1996). Expression and function of proenkepha-lin A messenger ribonucleic acid in murine fetal thymocytes. Endocrinology, 137(3), 857–863.
Liu, Y., Blackbourn, D. J., Chuang, L. F., Killam, K. F., Jr., & Chuang, R. Y. (1992). Effects of in vivo and in vitro administration of morphine sulfate upon rhesus macaque polymorphonuclear cell phagocytosis and chemotaxis. J Pharmacol Exp Ther, 263(2), 533–539.
Lokensgard, J. R., Gekker, G., & Peterson, P. K. (2002). Kappa-opioid receptor agonist inhibition of HIV-1 envelope glycoprotein-mediated membrane fusion and CXCR4 expression on CD4(+) lymphocytes. Biochem Pharmacol, 63(6), 1037–1041.
Lolait, S. J., Clements, J. A., Markwick, A. J., Cheng, C., McNally, M., Smith, A. I., & Funder, J. W. (1986). Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. J Clin Invest, 77(6), 1776–1779.
Louria, D. B., Hensle, T., & Rose, J. (1967). The major medical complications of heroin addiction. Ann Intern Med, 67(1), 1–22.
Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., & Dykstra, L. A. (1993a). Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther, 265(3), 1071–1078.
Lysle, D. T., Coussons, M. E., Watts, V. J., Bennett, E. H., & Dykstra, L. A. (1993b). Morphine-induced modulation of immune status: evidence for opioid receptor mediation and compartment specificity. Adv Exp Med Biol, 335, 53–59.
Lysle, D. T., Hoffman, K. E., & Dykstra, L. A. (1996). Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther, 277(3), 1533–1540.
Madden, J. J., Falek, A., Donahoe, R., Ketelson, D., & Chappel, C. L. (1990). Opiate binding sites on cells of the immune system. NIDA Res Monogr, 105, 103–108.
Madden, J. J., Whaley, W. L., & Ketelsen, D. (1998). Opiate binding sites in the cellular immune system: expression and regulation. J Neuroimmunol, 83(1–2), 57–62.
Mahajan, S. D., Schwartz, S. A., Shanahan, T. C., Chawda, R. P., & Nair, M. P. (2002). Morphine regulates gene expression of alpha- and beta-chemokines and their receptors on astroglial cells via the opioid mu receptor. J Immunol, 169(7), 3589–3599.
Makman, M. H., Bilfinger, T. V., & Stefano, G. B. (1995). Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis. J Immunol, 154(3), 1323–1330.
Mandler, R. N., Biddison, W. E., Mandler, R., & Serrate, S. A. (1986). Beta-endorphin augments the cytolytic activity and interferon production of natural killer cells. J Immunol, 136(3), 934–939.
McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K., & Rogers, T. J. (2001). Opioids, opioid receptors, and the immune response. Drug Alcohol Depend, 62(2), 111–123.
Mehrishi, J. N., & Mills, I. H. (1983). Opiate receptors on lymphocytes and platelets in man. Clin Immunol Immunopathol, 27(2), 240–249.
Nelson, C. J., Schneider, G. M., & Lysle, D. T. (2000). Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation. Brain Behav Immun, 14(3), 170–184.
Ovadia, H., Nitsan, P., & Abramsky, O. (1989). Characterization of opiate binding sites on membranes of rat lymphocytes. J Neuroimmunol, 21(2–3), 93–102.
Pacifici, R., Di Carlo, S., Bacosi, A., & Zuccaro, P. (1993). Macrophage functions in drugs of abuse-treated mice. Int J Immunopharmacol, 15(6), 711–716.
Perez-Castrillon, J. L., Perez-Arellano, J. L., Garcia-Palomo, J. D., Jimenez-Lopez, A., & De Castro, S. (1992). Opioids depress in vitro human monocyte chemotaxis. Immunopharmacology, 23(1), 57–61.
Peterson, P. K., Sharp, B., Gekker, G., Brummitt, C., & Keane, W. F. (1987a). Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. J Immunol, 138(11), 3907–3912.
Peterson, P. K., Sharp, B., Gekker, G., Brummitt, C., & Keane, W. F. (1987b). Opioid-mediated suppression of interferon-gamma production by cultured peripheral blood mononu-clear cells. J Clin Invest, 80(3), 824–831.
Peterson, P. K., Molitor, T. W., & Chao, C. C. (1993). Mechanisms of morphine-induced immunomodulation. Biochem Pharmacol, 46(3), 343–348.
Peterson, P. K., Gekker, G., Hu, S., Lokensgard, J., Portoghese, P. S., & Chao, C. C. (1999). Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor. Neuropharmacology, 38(2), 273–278.
Radulovic, J., Miljevic, C., Djergovic, D., Vujic, V., Antic, J., von Horsten, S., & Jankovic, B. D. (1995). Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of kappa opioid receptors. J Neuroimmunol, 57(1–2), 55–62.
Rojavin, M., Szabo, I., Bussiere, J. L., Rogers, T. J., Adler, M. W., & Eisenstein, T. K. (1993). Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macro-phages. Life Sci, 53(12), 997–1006.
Roy, S., & Loh, H. H. (1996). Effects of opioids on the immune system. Neurochem Res, 21(11), 1375–1386.
Roy, S., Ramakrishnan, S., Loh, H. H., & Lee, N. M. (1991). Chronic morphine treatment selectively suppresses macrophage colony formation in bone marrow. Eur J Pharmacol, 195(3), 359–363.
Roy, S., Loh, H. H., & Barke, R. A. (1995). Morphine-induced suppression of thymocyte proliferation is mediated by inhibition of IL-2 synthesis. Adv Exp Med Biol, 373, 41–48.
Roy, S., Chapin, R. B., Cain, K. J., Charboneau, R. G., Ramakrishnan, S., & Barke, R. A. (1997). Morphine inhibits transcriptional activation of IL-2 in mouse thymocytes. Cell Immunol, 179(1), 1–9.
Roy, S., Barke, R. A., & Loh, H. H. (1998). MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Brain Res Mol Brain Res, 61(1–2), 190–194.
Roy, S., Cain, K. J., Chapin, R. B., Charboneau, R. G., & Barke, R. A. (1998). Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun, 245(2), 392–396.
Ruff, M. R., Wahl, S. M., Mergenhagen, S., & Pert, C. B. (1985). Opiate receptor-mediated chemotaxis of human monocytes. Neuropeptides, 5(4–6), 363–366.
Sedqi, M., Roy, S., Ramakrishnan, S., Elde, R., & Loh, H. H. (1995). Complementary DNA cloning of a mu-opioid receptor from rat peritoneal macrophages. Biochem Biophys Res Commun, 209(2), 563–574.
Sei, Y., McIntyre, T., Fride, E., Yoshimoto, K., Skolnick, P., & Arora, P. K. (1991). Inhibition of calcium mobilization is an early event in opiate-induced immunosuppression. Faseb J, 5(8), 2194–2199.
Sei, Y., Yoshimoto, K., McIntyre, T., Skolnick, P., & Arora, P. K. (1991). Morphine-induced thymic hypoplasia is glucocorticoid-dependent. J Immunol, 146(1), 194–198.
Shahabi, N. A., & Sharp, B. M. (1995a). Antiproliferative effects of delta opioids on highly purified CD4 + and CD8 + murine T cells. J Pharmacol Exp Ther, 273(3), 1105–1113.
Shahabi, N. A., & Sharp, B. M. (1995b). Delta opioid agonists inhibit proliferation of highlypurified murine CD4 + and CD8 + T-cells. Adv Exp Med Biol, 373, 29–36.
Shahabi, N. A., McAllen, K., & Sharp, B. M. (2003). Phosphorylation of activating transcription factor in murine splenocytes through delta opioid receptors. Cell Immunol, 221(2), 122–127.
Shahabi, N. A., McAllen, K., & Sharp, B. M. (2006). Delta opioid receptors stimulate Akt-dependent phosphorylation of c-jun in T cells. J Pharmacol Exp Ther, 316(2), 933–939.
Sharp, B. M., Keane, W. F., Suh, H. J., Gekker, G., Tsukayama, D., & Peterson, P. K. (1985). Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology, 117(2), 793–795.
Sharp, B. M., Roy, S., & Bidlack, J. M. (1998). Evidence for opioid receptors on cells involved in host defense and the immune system. J Neuroimmunol, 83(1–2), 45–56.
Sharp, B. M., Li, M. D., Matta, S. G., McAllen, K., & Shahabi, N. A. (2000). Expression of delta opioid receptors and transcripts by splenic T cells. Ann N Y Acad Sci, 917, 764–770.
Shavit, Y., Depaulis, A., Martin, F. C., Terman, G. W., Pechnick, R. N., Zane, C. J., Gale, R. P., & Liebeskind, J. C. (1986). Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc Natl Acad Sci U S A, 83(18), 7114–7117.
Singhal, P. C., Reddy, K., Franki, N., Sanwal, V., & Gibbons, N. (1997). Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B. Inflammation, 21(6), 609–617.
Steele, A. D., Henderson, E. E., & Rogers, T. J. (2003). Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology, 309(1), 99–107.
Stefano, G. B., Melchiorri, P., Negri, L., Hughes, T. K., Jr., & Scharrer, B. (1992). [D-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells. Proc Natl Acad Sci USA, 89(19), 9316–9320.
Szabo, I., Rojavin, M., Bussiere, J. L., Eisenstein, T. K., Adler, M. W., & Rogers, T. J. (1993). Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther, 267(2), 703–706.
Taub, D. D., Eisenstein, T. K., Geller, E. B., Adler, M. W., & Rogers, T. J. (1991). Immunomodulatory activity of mu- and kappa-selective opioid agonists. Proc Natl Acad Sci USA, 88(2), 360–364.
Tegeder, I., & Geisslinger, G. (2004). Opioids as modulators of cell death and survival — unraveling mechanisms and revealing new indications. Pharmacol Rev, 56(3), 351–369.
Tosk, J. M., Grim, J. R., Kinback, K. M., Sale, E. J., Bozzetti, L. P., & Will, A. D. (1993). Modulation of chemiluminescence in a murine macrophage cell line by neuroendocrine hormones. Int J Immunopharmacol, 15(5), 615–620.
Tubaro, E., Borelli, G., Croce, C., Cavallo, G., & Santiangeli, C. (1983). Effect of morphine on resistance to infection. J Infect Dis, 148(4), 656–666.
Tubaro, E., Avico, U., Santiangeli, C., Zuccaro, P., Cavallo, G., Pacifici, R., Croce, C., & Borelli, G. (1985). Morphine and methadone impact on human phagocytic physiology. Int J Immunopharmacol, 7(6), 865–874.
Tubaro, E., Santiangeli, C., Belogi, L., Borelli, G., Cavallo, G., Croce, C., & Avico, U. (1987). Methadone vs morphine: comparison of their effect on phagocytic functions. Int J Immunopharmacol, 9(1), 79–88.
Vallejo, R., de Leon-Casasola, O., & Benyamin, R. (2004). Opioid therapy and immuno-suppression: a review. Am J Ther, 11(5), 354–365.
van Epps, D. E., & Saland, L. (1984). Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol, 132(6), 3046–3053.
Wang, J. B., Johnson, P. S., Imai, Y., Persico, A. M., Ozenberger, B. A., Eppler, C. M., & Uhl, G. R. (1994). cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett, 348(1), 75–79.
Weber, R. J., & Pert, A. (1989). The periaqueductal gray matter mediates opiate-induced immunosuppression. Science, 245(4914), 188–190.
Weber, R. J., Ikejiri, B., Rice, K. C., Pert, A., & Hagan, A. A. (1987). Opiate receptor mediated regulation of the immune response in vivo. NIDA Res Monogr, 76, 341–348.
Wick, M. J., Minnerath, S. R., Roy, S., Ramakrishnan, S., & Loh, H. H. (1996). Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol, 64(1), 29–36.
Wybran, J., Appelboom, T., Famaey, J. P., & Govaerts, A. (1979). Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol, 123(3), 1068–1070.
Yakovlev, A. G., Krueger, K. E., & Faden, A. I. (1995). Structure and expression of a rat kappa opioid receptor gene. J Biol Chem, 270(12), 6421–6424.
Yin, D., Mufson, R. A., Wang, R., & Shi, Y. (1999). Fas-mediated cell death promoted by opioids. Nature, 397(6716), 218.
Yin, D., Zhang, Y., Stuart, C., Miao, J., Zhang, Y., Li, C., Zeng, X., Hanley, G., Moorman, J., Yao, Z., & Woodruff, M. (2006). Chronic restraint stress modulates expression of genes in murine spleen. J Neuroimmunol, 177(1–2), 11–17.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Moorman, J., Yao, Z.Q., Bilsky, E.J., Yin, D. (2009). Opioid Receptor Antagonist-Mediated Signaling in the Immune System. In: Dean, R.L., Bilsky, E.J., Negus, S.S. (eds) Opiate Receptors and Antagonists. Contemporary Neuroscience. Humana Press. https://doi.org/10.1007/978-1-59745-197-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-59745-197-0_4
Publisher Name: Humana Press
Print ISBN: 978-1-58829-881-2
Online ISBN: 978-1-59745-197-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)